Os. Platt et al., MORTALITY IN SICKLE-CELL DISEASE - LIFE EXPECTANCY AND RISK-FACTORS FOR EARLY DEATH, The New England journal of medicine, 330(23), 1994, pp. 1639-1644
Background. Information on life expectancy and risk factors for early
death among patients with sickle cell disease (sickle cell anemia, sic
kle cell-hemoglobin C disease, and the sickle cell-P-thalassemias) is
needed to counsel patients, target therapy, and design clinical trials
. Methods. We followed 3764 patients who ranged from birth to 66 years
of age at enrollment to determine the life expectancy and calculate t
he median age at death. In addition, we investigated the circumstances
of death for all 209 adult patients who died during the study, and us
ed proportional-hazards regression analysis to identify risk factors f
or early death among 964 adults with sickle cell anemia who were follo
wed for at least two years. Results. Among children and adults with si
ckle cell anemia (homozygous for sickle hemoglobin), the median age at
death was 42 years for males and 48 years for females. Among those wi
th sickle cell-hemoglobin C disease, the median age at death was 60 ye
ars for males and 68 years for females. Among adults with sickle cell
disease, 18 percent of the deaths occurred in patients with overt orga
n failure, predominantly renal. Thirty-three percent were clinically f
ree of organ failure but died during an acute sickle crisis (78 percen
t had pain, the chest syndrome, or both; 22 percent had stroke). Model
ing revealed that in patients with sickle cell anemia, the acute chest
syndrome, renal failure, seizures, a base-line white-cell count above
15,000 cells per cubic millimeter, and a low level of fetal hemoglobi
n were associated with an increased risk of early death. Conclusions.
Fifty percent of patients with sickle cell anemia survived beyond the
fifth decade. A large proportion of those who died had no overt chroni
c organ failure but died during an acute episode of pain, chest syndro
me, or stroke. Early mortality was highest among patients whose diseas
e was symptomatic. A high level of fetal hemoglobin predicted improved
survival and is probably a reliable childhood forecaster of adult lif
e expectancy.